Vitamin E Decreases the Hyperglucagonemia of Diabetic Rats
- 28 November 2006
- journal article
- Published by Wiley in Annals of the New York Academy of Sciences
- Vol. 1084 (1) , 432-441
Abstract
Vitamin E has the ability to scavenge a wide spectrum of free radicals, including singlet oxygen, superoxide, and hydroxyl radicals. It has beneficial effects against several other disorders, such as atherosclerosis and ischemic heart disease, because it acts as a transcriptional regulator for gene expression via a transcription factor TAP. The beneficial effect of vitamin E on plasma insulin and glucagon levels was examined using radioimmunoassay technique. Diabetes was induced in rats by a single intraperitoneal injection of streptozotocin at a dose of 60 mg/kg body weight. Vitamin E was given at a dose of either 0.2 mg, 0.4 mg, or 0.8 mg per animal 10 days before and after the onset of diabetes. Vitamin E significantly (P < 0.05) increased plasma insulin levels in normal rats but failed to increase the plasma insulin level in diabetic rats. In contrast, vitamin E caused a significant (P < 0.05) reduction in plasma glucagon level in rats treated before and after the onset of diabetes. Vitamin E may ameliorate some diabetic complication via reduction in the level of circulating glucagon.Keywords
This publication has 15 references indexed in Scilit:
- Fasting Hyperglucagonemia in Patients with Transjugular Intrahepatic Portosystemic Shunts (TIPS)Experimental and Clinical Endocrinology & Diabetes, 2005
- Diet high in lipid hydroperoxide by vitamin E deficiency induces insulin resistance and impaired insulin secretion in normal ratsDiabetes Research and Clinical Practice, 2005
- Vitamin E Mediates Cell Signaling and Regulation of Gene ExpressionAnnals of the New York Academy of Sciences, 2004
- A randomized trial of nicotinamide and vitamin E in children with recent onset type 1 diabetes (IMDIAB IX)European Journal of Endocrinology, 2004
- Non‐antioxidant molecular functions of α‐tocopherol (vitamin E)FEBS Letters, 2002
- Tocopherol-Associated Protein Is a Ligand-Dependent Transcriptional ActivatorBiochemical and Biophysical Research Communications, 2001
- Distribution of neurotransmitters and their effects on glucagon secretion from the in vitro normal and diabetic pancreatic tissuesTissue and Cell, 2000
- Effect of subcutaneous pancreatic tissue transplants on streptozotocin-induced diabetes in rats. II. Endocrine and metabolic functionsTissue and Cell, 1999
- Development of Early Lesions of Microangiopathy in Chronically Diabetic MonkeysDiabetes, 1984
- Development of early lesions of microangiopathy in chronically diabetic monkeysDiabetes, 1984